Long-Term Effect of Early Phacoemulsification in Primary Angle Closure Glaucoma Patients with Cataract: A 10-Year Follow-Up Study

Purpose: To assess the 10-year effects of early phacoemulsification with intraocular lens (IOL) implantation in primary angle closure glaucoma (PACG) patients with cataract. Patients and Methods: This prospective cohort study included 102 eyes of 102 patients with PACG. All patients had coexisting cataracts compromising vision. Patients underwent phacoemulsification and foldable IOL implantation. The main outcome measures were anterior chamber depth (ACD), angle width, value of intraocular pressure (IOP), and number of medications needed postoperatively and during follow-up. Results: Half (53%) of the patients were female, with ages ranging from 55 to 73 with a mean of 59.82 +/- 5.19 years. Mean IOP decreased significantly from 22.15 +/- 2.08 mmHg at baseline to 14.08 +/- 2.13 mmHg postoperatively (p< 0.05). The ACD increased from 2.2 +/- 0.21 preoperatively to 3.73 +/- 0.25 postoperatively (p<0.001). Nasal angle width increased postoperatively to 40.05 +/- 2.09 compared to the preoperative value of 16.02 +/- 2.08 (p<0.001). Temporal angle width increased from 13.05 +/- 2.07 to 41.9600 +/- 1.94 (p<0.001). Anti glaucoma treatment significantly decreased postoperatively (p<0.001). A significant positive correlation was detected between ACD and angle width, while a negative correlation was detected between IOP and both ACD and angle width (p<0.001). There was also a significant negative correlation between postoperative angle width and IOP (p<0.001). Preoperative lens thickness was positively correlated with preoperative IOP and number of medications, while it was negatively correlated with preoperative AC depth and angle width. Preoperative lens thickness positively correlated with postoperative IOP and medications. Complete and qualified success was achieved in 69.65% and 30.4% of cases, respectively, while 2.9% failed to be controlled. Visual acuity significantly improved from 0.17 +/- 0.1 to 0.9 +/- 0.08 (p<0.001). All parameters showed high stability throughout the follow-up period. Conclusion: Phacoemulsification with IOL implantation is a safe and effective early modality for long-term control of IOP in PACG patients with coexisting cataract. The effects can persist for at least 10 years.